🟢 Immunic is trading 11% up with no confirmed company-specific catalyst

Immunic is trading 10.71% up at $8.37 as of 11:59 a.m. ET on October 9, 2026, with no confirmed company-specific catalyst identified.

• The latest company announcement, on October 7, concerned abstracts for a multiple-sclerosis meeting later in October; available reporting does not connect it to the move.
• The supplied sector context reports XBI up 2.50%, alongside new biotech IPOs and deal activity. This may offer a sector backdrop, but does not confirm a reason for Immunic’s larger move.